AT2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism

Hypertension

Volumn 31, Issue 1, 1998, Pages 349-355

  Gohlke, Peter ^a   Pees, Christiane ^a   Unger, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN ANTAGONIST; BRADYKININ RECEPTOR; ICATIBANT; LOSARTAN; MINOXIDIL; NITRIC OXIDE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; BRADYKININ; CYCLIC GMP; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; N(G) NITROARGININE METHYL ESTER; PYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; ANIMAL; AORTA; BLOOD; BLOOD PRESSURE; CEREBROVASCULAR DISEASE; DRUG ANTAGONISM; HYPERTENSION; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REFERENCE VALUE; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; BRADYKININ; CEREBROVASCULAR DISORDERS; CYCLIC GMP; HYPERTENSION; IMIDAZOLES; LOSARTAN; MALE; MINOXIDIL; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; PYRIDINES; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECEPTORS, BRADYKININ; REFERENCE VALUES;

EID: 0031611616     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.31.1.349     Document Type: Article

References (37)

1. Edling O, Gohlke P, Paul M, Rettig R, Stauss HM, Steckelings UM, Unger T. The renin-angiotensin system: physiology and pathophysiology. In: Schachter M, ed. ACE Inhibitory: Current Use and Future Prospects. Martin Duniz, London; 1995:3-41.
2. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
3. Unger T, Chung O, Cikos T, Culman J, Gallinat S, Gohlke P, Hohle S, Meffert S, Stoll M, Stroth U, Zhu YZ. Angiotensin receptors. J Hypertens. 1996;14(suppl 15):S95-S103.
4. Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol. 1997;36:281-306.
5. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev. 1995;47:25-49.
6. Gohlke P, Lamberty V, Kuwer I, Bartenbach S, Schnell A, Linz W, Scholkens BA, Wiemer G, Unger T. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate. Hypertension. 1993;22:682-687.
7. Gohlke P, Linz W, Scholkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension. 1994;23:411-418.
8. Gohlke P, Kuwer I, Bartenbach S, Schnell A, Unger T. Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin. J Cardiovasc Pharmacol. 1994;24:462-469.
9. Gohlke P, Linz W, Scholkens BA, Wiemer G, Unger T. Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Hypertension. 1996;28:397-402.
10. Campbell DJ, Kladis A, Valentijn AJ. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J Cardiovasc Pharmacol. 1995;26:233-240.
11. Wiemer G, Scholkens BA, Busse R, Wagner A, Heitsch H, Linz W. The functional role of angiotensin II-subtype AT2-receptors in endothelial cells and isolated ischemic rat hearts. Pharm Pharmacol Lett. 1993;3:24-27.
12. 1 -mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension. 1995;26:752-757.
13. Seyedi N, Xu XB, Nasjiletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
14. Munzenmaier DH, Greene AS. Stimulation of soluble guanylate cyclase activity by angiotensin II is mediated by a non-AT1 receptor mechanism in rat aorta. FASEB J. 1994;8:A367. Abstract 2124.
15. 2 production in conscious rats. J Clin Invest. 1996;97:1978-1982.
16. Liu YH, Yand XP, Sharov VG, Nass O, Sabbah HN, Peterson E, Carretero OA. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. J Clin Invest. 1997;99:1926-1935.
17. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp MADH. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension. 1990;15:44-55.
18. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PBMWM. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Hypertension. 1990;15:459-468.
19. Macari D, Whitebread S, Cumin F, De Gasparo M, Levens N. Renal actions of the angiotensin AT2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system. Eur J Pharmacol. 1994;259:27-36.
20. Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Frew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM. Proposed update of angiotensin receptor nomenclature. Hypertension. 1995;25:924-927.
21. Keiser JA, Major TC, Lu GH, Davis LS, Panek RL. Is there a functional cardiovascular role for AT2 receptors. Drug Dev Res. 1993;29:94-99.
22. Viswanathan M, Tsutsumi K, Correa FMA, Saavedra JM. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun. 1991;179:1361-1367.
23. Song K, Kurobe Y, Kanehara H, Wada T, Inada Y, Nishikawa K, Miyazaki M. Mapping of angiotensin II receptor subtypes in peripheral tissues of spontaneously hypertensive rats by in vitro autoradiography. Clin Exp Pharmacol Physiol. 1995;(suppl 1):S17-S19.
24. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
25. 1 receptors in endothelial cells. Br J Pharmacol. 1996;118:79-84.
26. Kambayashi Y, Bardhan S, Inagami T. Peptide growth factor markedly decrease the ligand binding of angiotensin II type 2 receptor in rat cultured vascular smooth muscle. Biochem Biophys Res Commun. 1993;194:478-482.
27. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension. 1997;29(part 2):388-393.
28. Mineo C, Shimizu H, Takada K-I, Imanaka Z, Takano T. Angiotensin II binding activity in cultured porcine arterial endothelial cells. Biochem Pharmacol. 1994;48:1993-1995.
29. Korth P, Fink E, Linz W, Scholkens BA, Wohlfart P, Wiemer G. Angiotensin II receptor subtype-stimulated formation of endothelial cyclic GMP and prostacyclin is accompanied by an enhanced release of endogenous kinins. Pharm Pharmacol Lett. 1995;3:124-127.
30. Paula RD, Lima CV, Khosla M, Santos RAS. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension. 1995;26 (part 2):1154-1159.
31. Abbas A, Gorelik G, Carbini LA, Scicli AG. Angiotensin-(1-7) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension. 1997;30 (part 1):217-221.
32. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27(part 2):523-528.
33. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
34. Porsti I, Bara AT, Busse R, Hecker M. Corrigendum: Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1996;117:231.
35. Guan H, Cachofeiro V, Pucci ML, Kaminski PM, Wolin MS, Nasjletti A. Nitric oxide and the depressor response to angiotensin blockade in hypertension. Hypertension. 1996;27:19-24.
36. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JS. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest. 1996;98:418-425.
37. Scheuer DA, Perrone MH. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol. 1993;264:R917-R923.